Crossmark

Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation

Crossref DOI link: https://doi.org/10.1007/s00277-015-2461-5

Published Online: 2015-08-02

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tschan-Plessl, A.

Halter, J. P.

Heim, D.

Medinger, M.

Passweg, J. R.

Gerull, S.
License Information

Text and Data Mining valid from 2015-08-02